CGON - CG Oncology, Common stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CGON is currently covered by 3 analysts with an average price target of $62.41. This is a potential upside of $35.66 (133.31%) from yesterday's end of day stock price of $26.75.

CG Oncology, Common stock's activity chart (see below) currently has 0 price targets and 14 ratings on display. The stock rating distribution of CGON is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for CGON is $66, Lowest price target is $66, average price target is $70.5.

Most recent stock forecast was given by GREGORY RENZA from RBC on 06-Dec-2024. First documented stock forecast 20-Feb-2024.

Best performing analysts who are covering CGON - CG Oncology, Common stock:

Josh Schimmer Gregory Renza

Currently out of the existing stock ratings of CGON, 14 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$66

$39.25 (146.73%)

$66

7 months 14 days ago
(06-Dec-2024)

0/2 (0%)

$31.41 (90.81%)

Buy

$75

$48.25 (180.37%)

$75

1 years 2 months 14 days ago
(06-May-2024)

0/3 (0%)

$39.9 (113.68%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CGON (CG Oncology, Common stock) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on CGON (CG Oncology, Common stock) with a proven track record?

JOSH SCHIMMER

Which analyst has the current lower performing score on CGON (CG Oncology, Common stock) with a proven track record?

GREGORY RENZA

Which analyst has the most public recommendations on CGON (CG Oncology, Common stock)?

Josh Schimmer works at CANTOR FITZGERALD and has 3 price targets and 2 ratings on CGON

Which analyst is the currently most bullish on CGON (CG Oncology, Common stock)?

Josh Schimmer with highest potential upside - $48.25

Which analyst is the currently most reserved on CGON (CG Oncology, Common stock)?

Gregory Renza with lowest potential downside - $39.25

CG Oncology, Common stock in the News

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs

NetworkNewsWire Editorial Coverage NEW YORK, July 7, 2025 /CNW/ — An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year worldwide (https://ibn.fm/dyQrw) with these numbers expected to grow. The American Cancer Society projects that by 2050, 35 million people will be diagnosed with cancer every year....

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?